lobbying_activities: 2865110

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2865110	83b5ea3b-4d30-43ad-aa1d-2d7c676038c4	Q3	STONINGTON GLOBAL	401105189	SORRENTO THERAPEUTICS, INC.	2022	third_quarter	CSP	Advancing regulatory approval of safe and non-addictive therapies for pain management.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	150000		0	0	2022-10-14T11:47:11-04:00